SEC Filing Summary: Amedica Corporation (Form 8-K)
Business Context and Reporting Period
This Form 8-K was filed by Amedica Corporation on March 31, 2014. The report announces the financial results for the fourth quarter of fiscal year 2013. The filing incorporates a press release (Exhibit 99.1) by reference but explicitly states that the information is not deemed "filed" under Section 18 of the Securities Exchange Act of 1934.
Note: The request metadata references "Sintx Technologies, Inc.", but the filing text identifies the registrant as "Amedica Corporation".
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These details are contained within the attached press release (Exhibit 99.1), which is not included in the provided source text.
Material Changes
The filing does not disclose specific material changes versus the prior comparable period. It serves solely as a notification that fourth-quarter fiscal 2013 results have been issued.
Guidance, Outlook, and Risks
The provided text contains no management commentary, forward-looking guidance, risk factors, contingencies, or unusual items. The document is a procedural report referencing an external press release.
Investor Verification Checklist
- Verify the correct registrant name (Amedica Corporation vs. Sintx Technologies, Inc.).
- Locate and review Exhibit 99.1 (Press Release dated March 31, 2014) for actual financial figures.
- Confirm the specific revenue and net income figures for Q4 FY2013 from the press release.
- Check for any forward-looking statements or guidance included in the referenced press release.